Regioselective O-derivatization of quercetin via ester intermediates. An improved synthesis of rhamnetin and development of a new mitochondriotropic derivative

Molecules

Volumn 15, Issue 7, 2010, Pages 4722-4736

  Mattarei, Andrea ^a   Biasutto, Lucia ^a   Rastrelli, Federico ^a   Garbisa, Spiridione ^a   Marotta, Ester ^a   Zoratti, Mario ^a,b   Paradisi, Cristina ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNR   (Italy)

Author keywords

Mitochondrial targeting; Polyphenols; Quercetin; Regioselective alkylation; Rhamnetin

Indexed keywords

DRUG DERIVATIVE; ESTER; QUERCETIN; RHAMNETIN;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; MITOCHONDRION; SYNTHESIS;

ANIMALS; ESTERS; HUMANS; MITOCHONDRIA; MOLECULAR STRUCTURE; QUERCETIN;

EID: 77954978354     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15074722     Document Type: Article

References (30)

1. Bischoff, S.C. Quercetin: Potentials in the prevention and therapy of disease. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11, 733-740.
2. Murakami, A.; Ashida, H.; Terao, J. Multitargeted cancer prevention by quercetin. Cancer Lett. 2008, 269, 315-325.
3. Boots, A.W.; Haenen, G.R.; Bast, A. Health effects of quercetin: From antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585, 325-337.
4. Hirpara, K.V.; Aggarwal, P.; Mukherjee, J.; Joshi, N.; Burman, A.C. Quercetin and its derivatives: Synthesis, pharmacological uses with special emphasis on anti-tumor properties and prodrug with enhanced bio-availability. Anticancer Agents Med. Chem. 2009, 9, 138-161.
5. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Rémésy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81 (Suppl. 1), 230S-242S.
6. Williamson, G.; Manach, C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. 2005, 81 (Suppl. 1), 243S-255S.
7. Silberberg, M.; Morand, C.; Mathevon, T.; Besson, C.; Manach, C.; Scalbert, A., Rémésy, C. The bioavailability of polyphenols is highly governed by the capacity of the intestine and of the liver to secrete conjugated metabolites. Eur. J. Nutr. 2006, 45, 88-96.
8. Biasutto, L.; Marotta, E.; De Marchi, U.; Zoratti, M.; Paradisi, C. Ester-based precursors to increase the bioavailability of quercetin. J. Med. Chem. 2007, 50, 241-253.
9. Biasutto, L.; Marotta, E.; Mattarei, A.; Beltramello, S.; Caliceti, P.; Salmaso, S.; Bernkop-Schnürch, A.; Garbisa, S.; Zoratti, M.; Paradisi, C. Absorption and metabolism of resveratrol carboxyesters and methanesulfonate by explanted rat intestinal segments. Cell. Physiol. Biochem. 2009, 24, 557-566.
10. Mattarei, A.; Biasutto, L.; Marotta, E.; De Marchi, U.; Sassi, N.; Garbisa, S.; Zoratti, M.; Paradisi, C. A mitochondriotropic derivative of quercetin: A strategy to increase the effectiveness of polyphenols. ChemBioChem 2008, 16, 2633-2642.
11. Biasutto, L.; Mattarei, A.; Marotta, E.; Bradaschia, A.; Sassi, N.; Garbisa, S.; Zoratti, M.; Paradisi, C. Development of mitochondria-targeted derivatives of resveratrol. Bioorg. Med. Chem. Lett. 2008, 18, 5594-5597.
12. Biasutto, L.; Sassi, N.; Mattarei, A.; Marotta, E.; Cattelan, P.; Toninello, A.; Garbisa, S.; Zoratti, M.; Paradisi, C. Impact of mitochondriotropic quercetin derivatives on mitochondria. Biochim. Biophys. Acta 2010, 1797, 189-196.
13. Hoye, A.T.; Davoren, J.E.; Wipf, P.; Fink, M.P.; Kagan, V.E. Targeting mitochondria. Acc. Chem. Res. 2008, 41, 87-97.
14. Murphy, M.P.; Smith, R.A. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu. Rev. Pharmacol. Toxicol. 2007, 47, 629-656.
15. Murphy, M.P. Targeting lipophilic cations to mitochondria. Biochim. Biophys. Acta 2008, 1777, 1028-1031.
16. Skulachev, V.P.; Anisimov, V.N.; Antonenko, Y.N.; Bakeeva, L.E.; Chernyak, B.V.; Erichev, V.P.; Filenko, O.F.; Kalinina, N.I.; Kapelko, V.I.; Kolosova, N.G.; Kopnin, B.P.; Korshunova, G.A.; Lichinitser, M.R.; Obukhova, L.A.; Pasyukova, E.G.; Pisarenko, O.I.; Roginsky, V.A.; Ruuge, E.K.; Senin, I.I.; Severina, I.I.; Skulachev, M.V.; Spivak, I.M.; Tashlitsky, V.N.; Tkachuk, V.A.; Vyssokikh, M.Y.; Yaguzhinsky, L.S.; Zorov, D.B. An attempt to prevent senescence: A mitochondrial approach. Biochim. Biophys. Acta 2009, 1787, 437-461.
17. Metodiewa, D.; Jaiswal, A.K.; Cenas, N.; Dickancaité, E. Quercetin may act as a cytotoxic prooxidant afyer its metabolic activation to semiquinone and quinoidal product. Free Radic. Biol. Med. 1999, 26, 107-116.
18. Sarno, S.; Moro, S.; Meggio, F.; Zagotto, G.; Dal Ben, D.; Ghibellini, P.; Battistutta, R.; Zanotti, G.; Pinna, L.A. Toward the rational design of protein kinase casein kinase-2 inhibitors. Pharmacol. Ther. 2002, 93, 159-168.
19. van Dijk, C.; Driessen, A.; Recourt, K. The uncoupling efficiency and affinity of flavonoids for vesicles. Biochem. Pharmacol. 2000, 60, 1593-1600.
20. Montenegro, L.; Carbone, C.; Maniscalco, C.; Lambusta, D.; Nicolosi, G.; Ventura, C.A.; Puglisi, G. In vitro evaluation of quercetin-3-O-acyl esters as topical drugs. Int. J. Pharm. 2007, 336, 257-262.
21. Bouktaib, M.; Lebrun, S.; Atmani, A.; Rolando, C. Hemisynthesis of all the O-monomethylated analogues of quercetin including the major metabolites, through selective protection of phenolic functions. Tetrahedron 2002, 58, 10001-10009.
22. Hodnick, W.F.; Duval, D.L.; Pardini, R.S. Inhibition of mitochondrial respiration and cyanide-stimulated generation of reactive oxygen species by selected flavonoids. Biochem. Pharmacol. 1994, 47, 573-580.
23. Picq, M.; Prigent, A.F.; Némoz, G.; André, A.C.; Pacheco, H. Pentasubstituted quercetin analogues as selective inhibitors of particulate 3':5'-cyclic-AMP phosphodiesterase from rat brain. J. Med. Chem. 1982, 25, 1192-1198.
24. Op de Beck, P.; Dijoux, M.G.; Cartier, G.; Mariotte, A.-M. Quercitrin-3'-sulphate from leaves of Leea guinensis. Phytochemistry 1998, 47, 1171-1173.
25. Rietjens, I.M.; Awad, H.M.; Boersma, M.G.; van Iersel, M.L.; Vervoort, J.; Van Bladeren, P.J. Structure activity relationship for the chemical behaviour and toxicity of electrophilic quinones/quinone methides. Adv. Exp. Med. Biol. 2001, 500, 11-21.
26. Needs, P.W.; Williamson, G. Syntheses of daidzein-7-yl beta-D-glucopyranosiduronic acid and daidzein-4',7-yl di-beta-D- glucopyranosiduronic acid. Carbohydr. Res. 2001, 330, 511-515.
27. Shin, J.S.; Kim, K.S.; Kim, M.B.; Jeong, J.H.; Kim, B.K. Synthesis and hypoglycemic effect of chrysin derivatives. Bioorg. Med. Chem. Lett. 1999, 9, 869-874.
28. Li, M.; Han, X.; Yu, B. Facile synthesis of flavonoid 7-O-glycosides. J. Org. Chem. 2003, 17, 6842-6845.
29. Musialik, M.; Kuzmicz, R.; Pawlowski, T.S.; Litwinienko, G. Acidity of hydroxyl groups: An overlooked influence on antiradical properties of flavonoids. J. Org. Chem. 2009, 74, 2699-2709.
30. Piotto, M.; Bourdonneau, M.; Elbayed, K.; Wieruzeski, J.M.; Lippens, G. New DEFT sequences for the acquisition of one-dimensional carbon NMR spectra of small unlabelled molecules. Magn. Reson. Chem. 2006, 44, 943-947.